Pharmaceutical Manufacturing in India

Ajanta Pharma Ltd

Ajanta Pharma Limited is a pharmaceutical company headquartered in Mumbai, India. It has strong presence in Branded Generic business in India & Emerging markets; and Generic business in USA. In India, company operates in selected therapeutic areas of Cardiology, Dermatology, Ophthalmology, and Pain management. Recently Ajanta also got into two new promising therapies of Nephrology and Gynaecology. Its brands hold leadership positions in sub-therapeutic areas they are present in. In Emerging Markets, company has presence in Africa, South East Asia, West Asia, and CIS on broader therapeutic segments such as antimalarial, gastro, antibiotics, cardiology, dermatology, pain management, etc. As on 30th Sep 2025, Ajanta has 50 ANDA approvals which are commercialised. It holds 2 tentative approvals and 22 ANDAs are awaiting US FDA approval. Company plans to file 8-12 ANDAs every year. Company has state-of-the-art research facilities for formulation and API development located at Mumbai, India. R&D capabilities are evident from number of 1st to market products launched by the company providing patients most needed compliance and convenience. A dedicated and focused team of over 850 scientists work for R&D, which is growing continuously. Ajanta has 6 formulations manufacturing facilities located in India. Besides that, it also has an API manufacturing facility located at Waluj, India. Ajanta’s flagship formulation facilities at Paithan (Maharashtra, India) and Dahej (Gujarat, India) have been approved by US FDA. Ajanta continuously invests in enhancing the existing manufacturing facilities to meet current cGMP requirements and also construct new facilities to meet company’s growth requirements. Please visit https://ajantapharma.com/ for more information.

10001+ staff

Aurobindo Pharma Ltd

Aurobindo Pharma Limited (NSE: AUROPHARMA, BSE: 524804, Reuters: ARBN.NS, Bloomberg: ARBP IN) is an integrated global pharmaceutical company headquartered in Hyderabad, India. The Company develops, manufactures, and markets a wide range of generic pharmaceuticals, branded specialty drugs, and active pharmaceutical ingredients (APIs) across more than 150 countries. It is ranked among the top 10 generic companies in eight European nations and holds the distinction of being the largest generic pharmaceutical company in the United States. With over 30 state-of-the-art manufacturing and packaging facilities approved by leading global regulatory authorities including USFDA, UK MHRA, EDQM, Japan PMDA, WHO, Health Canada, South Africa MCC, and Brazil ANVISA, Aurobindo Pharma ensures the highest standards of quality. Its robust portfolio spans eight major therapeutic areas: Central Nervous System (CNS), Antiretroviral (ARV), Cardiovascular (CVS), Antibiotics, Gastroenterology, Anti-diabetics, Oncology, and Dermatology, supported by a strong R&D infrastructure that drives innovation, affordability, and accessibility.

10001+ staff

Ranbaxy

Ranbaxy Laboratories Limited, India's largest pharmaceutical company, is an integrated, research based, international pharmaceutical company, producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies. Ranked 8th amongst the global generic pharmaceutical companies, Ranbaxy today has a presence in 23 of the top 25 pharmaceutical markets of the world. The Company has a global footprint in 49 countries, world-class manufacturing facilities in 11 countries and serves customers in over 125 countries. In June 2008, Ranbaxy entered into an alliance with one of the largest Japanese innovator companies, Daiichi Sankyo Company Ltd, to create an innovator and generic pharmaceutical powerhouse. The combined entity now ranks among the top 15 pharmaceutical companies, globally. The transformational deal will place Ranbaxy in a higher growth trajectory and it will emerge stronger in terms of its global reach and in its capabilities in drug development and manufacturing. Vision & Aspirations Ranbaxy is driven by its vision to achieve significant business in proprietary prescription products by 2012 with a strong presence in developed markets. The Company aspires to be amongst the Top 5 global generic players and aims at achieving global sales of US $5 Bn by 2012. Financials Ranbaxy was incorporated in 1961 and went public in 1973. For the year 2008, the Company recorded Global Sales of US $ 1,682 Mn, reflecting a growth of 4%. The Company has a balanced mix of revenues from emerging and developed markets that contribute 54% and 39% respectively. In 2008, North America, the Company's largest market contributed sales of US $ 449 Mn, followed by Europe garnering US $ 330 Mn. Business in Asia has been going strong with India clocking sales of around US $ 300 Mn with market leadership in several business segments, backed by strong brand-building skills.

10001+ staff

Sun Pharma

Sun Pharma is the world's fourth-largest speciality generic pharmaceutical company and No. 1 in India. We provide high-quality, affordable medicines trusted by customers and patients in over 100 countries. Sun Pharma's global presence is supported by more than 40 manufacturing facilities spread across 5 continents, R&D centres across the globe, and a multicultural workforce comprising over 50 nationalities. Sun Pharma fosters excellence through innovation supported by strong R&D capabilities comprising around scientists and R&D investments of over 6-8% of annual revenues. At Sun, our people are our greatest asset. Ours has never been a story of individual brilliance but of cultivating a culture of realising collective potential. In our journey, everyone is enabled to take charge in an environment that offers limitless growth opportunities. We are with you every step of the way, so you can shine for years to come. With the launch of our Employee Value Proposition (EVP), we define our promise to ‘Create Your Own Sunshine'—driven by the three pillars of Better Every Day, Take Charge, and Thrive Together. These pillars drive progress at Sun so that people can achieve what they would have thought impossible. Learn more about our EVP here: https://sunpharma.com/careers/

10001+ staff

Torrent Pharmaceuticals Ltd

Torrent Pharma, with annual revenues of more than Rs 10,700 crores, is the flagship Company of the Torrent Group, with group revenues of Rs crores. It is ranked 5th in the Indian Pharma Market and is among the Top 5 in the therapeutic segments of Cardiovascular (CV), Central Nervous System (CNS), Gastro-intestinal (GI), Vitamins Minerals Nutritionals (VMN) and Cosmo-Dermatology. The Company also has significant presence in diabetology, pain management, gynaecology, oncology and anti-infective segments. Torrent has 8 manufacturing facilities, of which 5 are USFDA approved. With R&D as the backbone for its growth in domestic & overseas market, it has invested significantly in R&D capabilities with state-of-the-art R&D infrastructure employing around 800 scientists. The acquisition of Elder Pharma's Indian branded business in 2013, Dermaceuticals business of Zyg Pharma in 2015, API plant of Glochem Industries in 2016, Women healthcare brands from Novartis and Unichem's Indian branded business along with its Sikkim Plant in 2017 strengthened Torrent Pharma's position in the Indian Pharma market. Torrent Pharma started international acquisitions in 2005 with entry into the German market. Today, the Company has presence in more than 50 countries and is ranked No. 1 among the Indian pharma Companies in Brazil and Germany. Torrent Pharma is committed towards “not just healthcare but lifecare.”

10001+ staff

Alkem Laboratories Ltd

A single idea, which sprouts from a human mind, contains the potential to create marvels that can influence generations. It can redefine rules, it can transform the world. Back in the year 1973, a team of individuals came with such an idea – The idea called Alkem. It was highly potent and resilient, like a spark that could ignite a thousand more ideas. And it did! Looking back at our 4 decade, illustrious journey, that one small idea has Not only triggered us to become one of India’s largest generic and specialty pharmaceutical company but also, create a foothold in over 50 countries 32% of our revenue is generated via offshore sales. As well as we have consistently been ranked amongst the top ten pharmaceutical companies in India. Our portfolio includes illustrious brands like Clavam, Pan, Pan-D and Taxim-O, which feature amongst top 50 pharmaceutical brands in India. For over a decade, our dominance in anti-infective segment has remained unchallenged. We have 21 manufacturing facilities at multiple locations in India and the United States of America. Our upper-crest facilities are inspected and audited as per cGMP guidelines as laid down by leading regulatory authorities such as USFDA, MHRA - UK, SAHPRA-South Africa, TGA - Australia, ANVISA - Brazil, WHO - Geneva, TPD - Health Canada, PPB - Kenya, NDA - Uganda, MOH - Sudan, INVIMA - Colombia, TFDA - Tanzania, Zimbabwe, BfArM-Germany & Other Africa, Asian & CIS Countries. Another feather in our cap was added on December 23rd, 2015, when, Alkem completed it's Initial Public Offering (IPO) and was listed on the Bombay Stock Exchange Limited and the National Stock Exchange of India Limited. Although passion is the fuel that keeps ideas alive, innovation is the catalyst that gives it flight! With over 500 scientists working in 5 global R&D centers, we are empowering innovations that align with our philosophy of ‘Extended Lifecare Beyond Boundaries’.

10001+ staff

Mankind Pharma Ltd

Mankind Pharma, one of the top 5 leading pharmaceutical companies in India, started its journey in 1995. Today, we have an employee base of over and are racing towards $1 Billion. At Mankind, we aspire to aid the community in leading a healthy life by formulating, developing, commercializing, and delivering affordable and accessible medicines that satisfy urgent medical needs. We take great pride in the success of our products ranging from Pharma, OTC and FMCG brands like Manforce Condoms, Manforce Tablets, Manforce Staylong Gel, Unwanted 72, Prega News, Gas-O-Fast, Kaloree 1, Kabzend, Acne Star Gel and many others. Our operations are in 34 overseas destinations across Asia, Africa, South-East Asia, Gulf countries and CIS countries. Our Vision - To be a global pharmaceutical company, most admired for its Affordability, Quality and Accessibility of products. Our Mission - To be able to provide cost-effective, innovation based superior quality pharmaceutical products across the globe, to improve the lives of the patients. Mankind strongly believes and follows its Core Values: Commitment to Customer - Internal and External : It is in our DNA to maintain and deliver highest quality standards and products : Intensely Research driven organization aiming at product innovation and technology improvements : Always trustworthy, widely respected to be honest, and believed by everyone : Aim higher than capabilities : Together we are foreseeing future and diligently stimulating our people in attaining goals

10001+ staff

Akums Drugs& Pharmaceuticals Ltd

Akums Drugs & Pharmaceuticals Ltd. stands as India focused leading pharmaceutical Contract Development and Manufacturing company (CDMO), delivering a diverse range of formulations across various therapeutic segments. Partnering with top pharmaceutical companies domestically and globally, we operate 12 cutting-edge facilities dedicated to manufacturing oral solids, liquids, sterile injectables, hormonal treatments, and more. Our expertise extends to personal care, ayurvedic remedies, nutraceuticals, and animal healthcare solutions. We have also expanded into API manufacturing, further strengthening our capabilities. At Akums, we are committed to innovation, quality, and trust as we shape the future of healthcare.

10001+ staff

Glenmark Pharmaceuticals

Glenmark Pharmaceuticals Limited is a research-led, global organization committed to enriching lives. Innovation is deeply embedded in Glenmark’s culture; it is how we differentiate ourselves in our key markets and create greater value for our stakeholders. In our journey of innovation over the past four and a half decades, we have evolved from a generics company to a global organization offering specialty and branded products. Glenmark’s core values of Achievement, Respect, and Knowledge impart a sense of organizational unity that drives our growth. We have established a robust global branded generics, specialty, and OTC business; with a significant presence in the therapy areas of dermatology, respiratory, and oncology. Our ten state-of-the-art manufacturing facilities spread across four continents with operations in over 80 countries help us impact millions of patients across the globe. We recently consolidated our innovation efforts in small molecules and biologics research with the formation of ‘Ichnos Glenmark Innovation’ (IGI). This alliance is aimed at leveraging the capabilities of Glenmark and its subsidiary, Ichnos Sciences, to accelerate innovation in cancer treatment. To know more about IGI, check out: https://iginnovate.com/ Sustainability is an integral aspect of all our operations and we are focused on achieving our Environment, Social and Governance (ESG) goals. Our responsibility also extends to our communities, and over the years, our CSR efforts have touched the lives of over 3 million people.

10001+ staff

Intas Pharmaceuticals

Intas is one of the leading multinational pharmaceutical formulation development, manufacturing, and marketing organization in the world. It has been growing at 19% CAGR and crossed the $2.5 billion mark in the past financial year. The company has set up a network of subsidiaries, under the name Accord Healthcare in the EU, US, Canada, SA, Australia, APAC as well as CIS & MENA regions. Intas is present in 85+ countries, with more than 70% of its revenue coming from global business. Currently ranked 6th in the Indian pharmaceutical market, it’s the largest privately owned Indian generic pharma company. Intas has established leadership in key therapeutic segments like CNS, Cardio, Diabeto, Gastro, Urology, Oncology & Animal Health in India. We are among the top 10 generic players in the highly regulated markets of EU, US & UK. Intas operates 17 advanced formulations, R&D, and distribution facilities, of which 10 are in India and the rest in the UK, Mexico & Greece with the help of our Human Capital. Between them, the facilities are accredited by global regulators such as USFDA, EMA, MHRA, TGA, and others. The company invests ~6-7% of its revenues in R&D and has over product registrations worldwide with a strategic pipeline of 300+ high-value FTF/FTM, Biosimilars, and NDDS products. Intas' highly advanced EU-GMP Certified Biopharma division is fueled by a mission to provide affordable “Biosimilars for Billions” across niche segments such as oncology, auto-immune, ophthalmology, nephrology, rheumatology, and hormone-based therapies. The Plasma Fractionation Unit of Intas Pharmaceuticals is a pioneer in manufacturing plasma-derived therapeutics. It houses a full-fledged R&D lab and a state-of-the-art WHO-GMP-certified manufacturing facility complemented with a GLP-compliant QC lab. Our values of Innovation, Customer Delight, Ownership & Collaboration, Performance Focus & Care for Society are the driving forces toward excellence.

10001+ staff

Hetero

Hetero is one of India’s leading generic pharmaceutical companies and the world’s largest producer of anti-retroviral drugs. Backed by 30+ years of expertise in the pharmaceutical industry, Hetero’s strategic business areas spread across APIs, generics, biosimilars, custom pharmaceutical services and branded generics. The company is globally recognized for its strengths in Research and Development, manufacturing and commercialization of a wide range of products. Hetero has 36 plus state-of-the-art manufacturing facilities strategically located worldwide, approved by stringent global regulatory authorities. Our portfolio includes 400 plus products encompassing major therapeutic categories such as HIV/AIDS, Oncology, Cardiovascular, Neurology, Hepatitis, Nephrology, Urology, Diabetes, Ophthalmology, Hepatology and Immunology etc. Hetero has a strong global presence in over 145+ countries and focusses on making affordable medicines accessible to patients worldwide.

10001+ staff

Micro Labs Limited

Micro Labs Limited emerges as a preeminent technology-driven healthcare entity, recognized for its cutting-edge Research and Development (R&D) and state-of-the-art automation-driven manufacturing facilities. The company consistently excels in international regulatory audits, reinforcing its commitment to quality. Our noteworthy achievements are fortified by a robust distribution network and groundbreaking research initiatives, positioning us as one of India's rapidly growing healthcare entities. Notably, we hold the 14th rank in prescriptions and the 19th position in sales, attesting to our formidable presence in the industry. Micro's extensive brand portfolio encompasses top-tier offerings in various medical specialties such as Cardiology, Diabetology, Anti-infectives, Ophthalmology, Pain management, Dermatology, Neurology, and more. Our impressive portfolio includes acclaimed brands like DOLO, Caripill, Amlong, Lubrex, Tripride and many more, widely acknowledged and extensively prescribed for their effectiveness in various therapeutic areas. Beyond our commercial success, Micro Labs Limited maintains a steadfast commitment to social responsibility, actively aspiring to be a model corporate citizen. This dedication manifests in our initiatives focused on Environmental Protection and Social Initiatives, with substantial contributions in the spheres of education and health. For further insights, we invite you to explore our website at Caution Notice: Micro Labs adheres to a formalized recruitment process facilitated exclusively through its internal HR department. In the event that you encounter a suspicious job offer, we urge you to report it immediately. Please exercise caution and refrain from providing any personal information or making any payments. Genuine job seekers are advised to apply for current openings exclusively through the official Micro Labs website. You can communicate with us by writing to hrrecruit@microlabs.in

10001+ staff

Akums Group

The organization deals in the manufacturing and export of formulations in a wide spectrum of dosage forms & therapeutic segments. The company is currently supplying to almost all Indian and multinational pharmaceutical companies across the globe. The 9 state-of-the-art facilities are dedicated to Oral Solid Dosage forms (with separate units for Beta Lactum and Non-Beta Lactum formulations), Oral Liquid Dosage forms, Sterile Dosage forms (Injectable, eye, Ear & Nasal), Hormonal (Oral and Injectable), Ointments & Cosmetics, Ayurvedic, Food Supplements & Nutraceuticals.

10001+ staff

Alembic Pharmaceuticals Ltd

ALEMBIC PHARMACEUTICALS LTD is a pharmaceuticals company based out of Alembic Road, VADODARA, India.

10001+ staff

Ipca Laboratories Limited

A consumer-led global pharmaceutical company, creating healthy doses of life since 1949. When you operate in an industry like pharmaceuticals, your work goes way beyond creating ‘products for customers’. It is different from any other domain – there lies a higher sense of responsibiliti and a need for utmost integriti in everything you do. As you serve millions of lives, high qualiti standards become a pre-requisite, and safeti of your people and consumers always comes first. All this, while ensuring that each life you touch is treated with respect and digniti. For more than 60 years, Ipca has been a crucial healthcare partner in over 120 countries across the 6 continents. We are a fully-integrated pharmaceutical company that manufactures over 350 formulations and 80 APIs for various therapeutic segments. Today, we are one of the world’s largest manufacturers and suppliers of over a dozen APIs. These are produced from scratch at fully-automated manufacturing facilities, approved by the world’s most discerning drug regulatory authorities like UK-MHRA, EDQM-Europe, and WHO-Geneva, among others- One of the largest suppliers of these APIs worldwide with manufacturing leadership in over 12 APIs globally - 15 APIs & 11 Formulations manufacturing facility across the globe Leader in DMARDs (Disease Modifying Anti-Rheumatic Drugs) treatment for Rheumatoid Arthritis - Leading brands in Pain, Rheumatology, Antimalarials and Hair care therapy - 4 formulations rank amongst the top 300 brands of IPM as per IQVIA

10001+ staff

Lupin India

Welcome to Lupin India’s Knowledge platform, a forum specially designed to share curated medical knowledge with you. Lupin India, the fifth largest pharmaceutical company in the Indian Pharmaceutical Market (IPM) by value, contributes nearly quarter of Lupin Limited revenues. In last decade, Lupin India has grown faster than the market and emerged as a significant player in the space of Cardiology, Respiratory & Diabetology. Lupin India has been recognized as a preferred partner by the multi-nationals vying to grow their business in India. Strong field force, well-balanced product pipeline and committed leadership team makes Lupin India a promising player in the IPM. In our endeavor to partner with medical practitioners, we have developed this platform to provide valuable content including healthcare news and best practices. At Lupin we always strive to add value to your medical practice and this platform is one such initiative to address the unique needs of healthcare professionals. Less a social page, and more a learning and collaborative platform, Lupin India, intends to keep the medical fraternity abreast with clinically relevant and medically advanced information. The platform will empower the medical community to make better clinical decisions by facilitating the exchange of information, patient case studies, treatment guidelines, latest medical news and use of technology in healthcare. Let us make this platform a knowledge sharing marvel and use the networking capabilities to engage with the entire Medical Fraternity.

10001+ staff

Macleods Pharmaceuticals Ltd

A vertically integrated, Global Pharmaceutical Company. Established in 1989, we are engaged in developing, manufacturing, and marketing a wide range of formulations across several major therapeutic areas including anti-infectives, cardiovascular, anti-diabetic, dermatology, and hormone treatment. We develop, manufacture, and globally distribute a broad range of pharmaceutical products across therapies in multiple dosage forms such as solid orals, liquid orals, topical formulations, injectables (Dry Powder) metered dose inhalers and dry powder inhalers. Our Vision To be a leading global pharmaceutical company by providing high quality, affordable and innovative therapeutic solutions for patients with diverse medical needs. Our Mission To contribute towards improving patients’ quality of life across the globe, by providing effective and accessible medicines.

10001+ staff

Stallion Laboratories Pvt. Ltd

Stallion Laboratories incorporated in 1988 as an integrated private sector Pharmaceutical Formulation Manufacturer, has acquired an unmatched record of managing niche product in formulations with a WHO GMP approved production facility and GLP qualified stringent quality control. The path of success lies in its belief of creativity and no negotiation with the quality of work. Stallion Laboratories has emerged as a reputed pharmaceuticals company with a unique mix of inorganic and organic growth fuelled through a strategy of focused brand management, total quality management, zero defect manufacturing and customized selling concepts managed by a team of highly proficient industry professionals. Stallion Laboratories has established a wide network of distribution in the Indian market as well as on the international Arena with strategic alliances in the major Pharma markets viz. South Latin America, Africa, South East Asia, CIS region & Francophone countries. Stallion Laboratories is armed with WHO GMP, GLP & ISO 9001-2015 Certifications. Stallion Laboratories is coming up with Unit II which is proposed to be UK-MHRA, EU GMP & PICS approved plant. With its approval, Stallion aims to enter regulated markets.

10001+ staff

Dr. Reddy's Active Pharmaceutical Ingredients

Dr. Reddy’s supplies high-quality APIs to leading formulation manufacturers across the world, enabling them to develop affordable medicines for patients worldwide. We are the preferred API partner to pharma companies across the US, Europe, Latin America, Japan, China, Korea and emerging markets. Our global establishment is rooted in deep technical strengths established over the last 38 years in the development and manufacture of complex APIs such as steroids, peptides, complex long-chain molecules, and highly potent APIs (HPAIs /oncology drugs). We have strong technical and cross-functional teams including R&D, Quality, Engineering & Analytical departments. Our dedicated R&D teams are committed to developing complex products to meet the evolving API needs in the GMP environment. Dr. Reddy's manufactures a wide range of pharmaceuticals in India and overseas. Our API manufacturing facilities are operated following cGMP (ICH Q7) and are regularly inspected by international regulatory authorities. We have eight commercial USFDA inspected production units, six in India and one in Mexico and the UK. Our APIs have regulatory filings available in major markets across the world. For more information, visit our website. For our community guidelines on LinkedIn: please visit: https://rb.gy/cddj9c

10001+ staff

Cytel

Cytel is the world’s leading data-science CRO, driving advancements in human health through robust analytics and innovative clinical trial software. For nearly four decades, we have set the standard in adaptive trial design, leveraging extensive data insights to inform strategy throughout every phase of drug development and commercialization. Our mission is clear: accelerate drug development, enhance success rates, and deliver better patient outcomes. With a comprehensive suite of services from innovative trial design to end-to-end biometrics and real-world evidence, our specialized, multidisciplinary team ensures optimal strategies for preclinical research, trial execution, market access, and reimbursement. Headquartered in Cambridge, Massachusetts, Cytel has a global presence with over employees across North America, Europe, and Asia. Learn more about how Cytel is harnessing the power of data to advance human health at

1001 to 5000 staff

Laurus Labs Limited

Laurus labs is an innovation-driven¸ people-centric & client-focused organization offering a broad and integrated portfolio of products & services to the global pharmaceutical industry. Equipped with a world-class infrastructure manned by best-in-class personnel & driven by the core values of knowledge, innovation and excellence, within a relatively short period, Laurus labs emerged as a segment-leading manufacturer of high quality APIs, a preferred partner for NCE development & manufacture & a trusted source of specialty ingredients for the nutraceutical industry. Given the strengths, capabilities & experience, Laurus Labs is uniquely positioned to help its clients in their endeavor of ‘quicker to market’ & thus contributing towards improving access to quality & affordable healthcare worldwide.

5001 to 10000 staff

Netmeds Wholesale

Welcome to Netmeds Wholesale (B2B), Your One Stop Pharma Destination

10001+ staff

Zydus Group

The Zydus Group with an overarching purpose of empowering people with freedom to live healthier and more fulfilled lives, is an innovative, global life-sciences company that discovers, develops, manufactures, and markets a broad range of healthcare therapies. The group employs over people worldwide and is driven by its mission to unlock new possibilities in life-sciences through quality healthcare solutions that impact lives. The group aspires to transform lives through pathbreaking discoveries.

10001+ staff

Africure Pharmaceuticals Limited

Welcome to Africure Group Africure is a Pharmaceutical Company that is committed to improving African health by creating a series of Manufacturing Assets and developing Technical Capabilities in Sub Saharan Africa. The Company has its holding company in Mauritius and manufacturing subsidiary's in Cameroon, Cote D Ivoire, Namibia, Botswana, India and distribution subsidiary's in Burkina Faso, Cameroon and Nigeria. A new plant is under construction in Ethiopia. Further we have management contracts, by virtue of which we manage 2 plants in Tanzania and Mozambique. Sub-Saharan Africa is in desperate need of being self sufficient in terms of pharmaceutical formulations so as to eliminate shortages, counterfeit imports and also High Cost imports. and is encouraging investments in Pharmaceuticals. We believe that this is the right way forward and would like to encash this opportunity by initiating the set up of one plant each year. Setting up plants in virtually unknown territories is a big challenge, but does not worry us as its a been there done that 8 times story for us. In order to augment our growth we are constantly looking for outstanding talent in various spheres of Pharmaceutical Manufacturing related activities and offer a challenging and dynamic work environment with rewarding compensations. Our Vision Help Africa build sufficiency in Pharmaceuticals across key geographies. Our Mission Manufacture high quality essential medication In Africa By Africans For Africa.’

201 to 500 staff

Celon Laboratories Limited

Celon Labs is a leader in the development and marketing of specialty products which serve niche therapy areas. Using in-house research & development capabilities, operational flexibility, manufacturing and regulatory expertise, Celon has taken a wide variety of products from laboratory to the market. Celon Laboratories Limited is a specialty-focused pharmaceutical company with core competencies in Oncology and Critical Care. We are commited to create better quality of life by being at the forefront of research, manufacturing and marketing of high quality formulations. Celon manufactures and markets a comprehensive portfolio of Oncology products and a vital portfolio of critical care products with a commitment to deliver wellness across the globe. Celon’s branded formulations business has domestic & international reach with focus on Indian & ROW markets. Our future endeavour in Global generics is all set to foray into the regulated markets. Celon fulfills an important need in the medical community as a provider of broad portfolio of injectable pharmaceutical products, including difficult to manufacture and urgently needed medical products. Our strategically designed business model creates a value chain that drives profitability and extends affordability to the end customer. Our focus is to become a global branded generic player with R&D expertise in extensive technology platforms, thereby delivering innovative drug delivery systems for enhancing treatment standards in the chosen therapy areas. Our constant eye for continuous upgradations in technologies and quality management systems guarantees that our products meet international standards of quality, safety and efficacy. In our journey ahead, we are all set to break new grounds, explore new frontiers and achieve new milestones in creating value in lifecare.

501 to 1000 staff

Corel Pharma Chem

10001+ staff

Fermenta Biotech Limited

Established in 1951, Fermenta Biotech Limited (FBL) is one of the largest manufacturers of Vitamin D3 and a key global player. Headquartered in Thane, India, FBL caters to clientele across the globe, with a worldwide distribution network. Its state-of-the-art R&D centre is based at Thane, and world class manufacturing facilities are located in Kullu, Himachal Pradesh and Dahej, Gujarat. Apart from Vitamin D3, FBL also offers niche APIs, integrated biotechnology platforms such as enzymes for antibiotic synthesis as well as environmental solutions for waste water management and treatment.

501 to 1000 staff

Granules India Limited

Granules India Ltd. is a fully integrated pharmaceutical manufacturer. The Company manufactures Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs) and Finished Dosages (FDs) which are distributed in over 80 countries.

5001 to 10000 staff

Neuland Laboratories Limited

Founded in 1984, Neuland Labs is a globally recognised Contract Development and Manufacturing Organization (CDMO), offering comprehensive customised NCE development services. Our team comprises highly skilled scientists, engineers, and technicians who utilise their expertise and advanced technologies to address the complex and evolving requirements of our clients. We collaborate with pharmaceutical and biotechnology companies to support all aspects of their chemistry needs, ranging from early development stages to commercial manufacturing, including process development, optimisation, analytical testing, and regulatory compliance. Neuland Labs possesses the capabilities and flexibility to manage both single-step processes and complete synthesis, handling projects from lab to commercial supply. We provide quantities suitable for clinical trials as well as full commercial-scale production of new chemical entities (NCEs), key starting materials (KSMs), active pharmaceutical ingredients (APIs), and their intermediates, ensuring efficient tech transfer timelines.

1001 to 5000 staff

Raptim Research Pvt. Ltd

Welcome to Raptim Research Pvt. Ltd! Raptim, a global independent and internationally accredited Clinical Research Organization (“CRO”), established in 2005, supporting the end-to-end services under the Clinical Research domain - Bioequivalence, IVRT/IVPT & BCS Biowaiver option; for all Pharmaceutical companies worldwide. Raptim stands for “Rapid” and it acts as a catalyst to hasten the regulatory submissions and approvals of customers’ products. We are market leader among independent Indian CROs, with the highest quality standards and quick turnaround times. We have a strong regulatory track record and numerous accreditation/approvals from global regulatory agencies like USFDA, WHO, ISP Chile, NABL, DCGI & product approval from MCC, CANADA. TGA, MHRA and FDA-Korea. Raptim is a technologically advanced CRO with experienced professionals who apply innovative tools and processes to their clinical development. We believe that our experience in all aspects of clinical research management; places us in a unique position to assist Sponsor with unparalleled support. Services include end to end verticals as below: • BA/BE studies • Bio analytical services (Drug, Elemental, Vitamin, Hormones etc) • Dermatology • IVRT/IVPT • CACO2 studies • Patient Pk studies • Clinical Trial (phase-II – IV) • Long housing study - Phytonadione, KCL • Data management • Medical & Scientific Writing • Complex BE Studies - Controlled substance, Inhalation, Nasal Spray, Transdermal Patch, Suppository, female contraceptive ring, Hormonal study. Headquartered & operations in Navi Mumbai, and Business offices in INDIA and USA with employee strength of 350+ of varied ethnic backgrounds providing a culturally rich working environment. Raptim has the optimized resources and the right approach to deliver the results that will make the project a success. New state of the art clinical research facility, coming soon! Contact US: contact@raptimresearch.com

201 to 500 staff

Red Nucleus

Advancing knowledge to improve lives.™ We are a global strategic partner with decades of experience across the entire life sciences product lifecycle. We excel in providing our clients with unique insights and efficiencies to support them in their journey to improve health outcomes and ultimately the quality of people’s lives. By connecting our full suite of products and services from scientific and advisory services, market access, medical communications and learning and development, we are the “red thread” to lead our life sciences clients through transformational change to accelerate customer success. Visit the new rednucleus.com to learn more.

501 to 1000 staff

Syngene International Limited

Syngene International Ltd.(BSE: 539268, NSE: SYNGENE, ISIN: INE398R01022) is an integrated research, development, and manufacturing services company serving the global pharmaceutical, biotechnology, nutrition, animal health, consumer goods, and specialty chemical sectors. Syngene's more than scientists offer both skills and the capacity to deliver great science, robust data security, and quality manufacturing, at speed, to improve time-to-market and lower the cost of innovation. With a combination of dedicated research facilities for Amgen, Baxter, and Bristol-Myers Squibb as well as 2 Mn sq. ft of specialist discovery, development and manufacturing facilities, Syngene works with biotech companies pursuing leading-edge science as well as multinationals, including GSK, Zoetis and Merck KGaA. For more details, visit or write to us at bdc@syngeneintl.com

5001 to 10000 staff

Xellia Pharmaceuticals

Xellia Pharmaceuticals is the global leader in fermentation-based non-beta-lactam anti-infectives. We manufacture and supply Active Pharmaceutical Ingredients (APIs) as well as Finished Dosage Forms (FDFs) to over 500 pharmaceutical companies across 80 countries. The European Union and the World Health Organization recognize a variety of our products as essential and critical medicines, serving as crucial resources in the fight against severe infections and antimicrobial resistance. Headquartered in Denmark, Xellia Pharmaceuticals boasts a global footprint, with manufacturing sites in Copenhagen, Denmark; Budapest, Hungary; and Taizhou, China, alongside R&D and commercial operations in an additional seven locations around the world. We stand as the sole European manufacturer of several of our products and possess a rich legacy of over 120 years in the pharmaceutical industry.

1001 to 5000 staff

Zcl Chemicals Ltd

We (formerly Zandu Chemicals Ltd) are one of the fastest growing Pharmaceutical companies in India that combines the power of Science & Technology together. Established in 1991, we are headquartered in Mumbai and have a state-of- the- art US FDA successfully inspected facility with a capacity of 214 KL along with strong research & development capabilities strategically located in the industrial park of Ankleshwar, Gujarat. We are a 100% EOU (Export Oriented Unit) engaged in manufacturing and exports of advanced drug intermediates and Active Pharma Ingredients (APIs). We are a specialized Pharma company focusing on the niche therapeutic areas of CNS, ARVs and Controlled substances having tremendous future growth potential. By virtue of this niche focus we have registered an impressive growth over the years. Our strategy going forward is to further consolidate our pre-eminent position in the high growth therapeutic areas by expanding our capacity for present advanced intermediates and moving up the value chain by expanding capacity for APIs and diversifying product portfolio into the other high growth therapeutic areas. We are a US FDA, KFDA, WHO-GMP and Japanese MOH accredited company having certifications of ISO 9001, ISO 14001 and OHSAS 18001. We enjoy the CRISIL rating of A(-) and have SAP system in place. While over 90% of our revenue is from established markets, we are growing rapidly in the emerging markets. We have an established track record in pharma business with focus on low to medium volume and high value products.

201 to 500 staff

Zim Laboratories Limited

We are research driven pharmaceutical company who develop, manufacture and supply differentiated generic products in the oral solid dosage forms, both as pre-formulation intermediates as well as finished formulation for certain key therapeutic segments. We offer both pharmaceutical and nutraceutical products. We have in-house R&D capabilities to offer a range of non-infringing drug delivery solutions based on process technologies that bring patient compliance thereby reducing the cost of treatment.

501 to 1000 staff

Zydus Group

The Zydus Group with an overarching purpose of empowering people with freedom to live healthier and more fulfilled lives, is an innovative, global lifesciences company that discovers, develops, manufactures, and markets a broad range of healthcare therapies. The group employs over people worldwide and is driven by its mission to unlock new possibilities in life-sciences through quality healthcare solutions that impact lives. The group aspires to transform lives through pathbreaking discoveries. For more details visit Official Twitter handle:@ZydusUniverse Official Twitter handle:@ zyduslifesciences

10001+ staff

Aarti Drugs Limited

Aarti Drugs Limited – Your Trusted API Partner in a Regulated World At Aarti Drugs, we go beyond just manufacturing Active Pharmaceutical Ingredients (APIs) — we deliver trust, quality, and regulatory confidence to pharmaceutical partners across Europe and beyond. With nearly 40 years of experience, we’re proud to be the go-to API partner for companies operating in highly regulated markets. Whether you're launching a new formulation or scaling up existing production, we offer flexible, end-to-end solutions designed to help your business grow. 🧪 Focused Expertise in Anti-Inflammatory APIs We specialize in a broad portfolio with strong capabilities in key anti-inflammatory compounds like: • Aceclofenac • Celecoxib • Diclofenac • Nimesulide … and more — all tailored for regulated markets and manufactured in EU-compliant facilities with full documentation support. Why European Pharma Trusts Us Seamless Global Exports – backed by an experienced logistics team Regulatory Confidence – from dossiers to DMFs, we’ve got you covered Custom Solutions – including tailored packaging and flexible delivery formats Free Development Samples – to support your R&D and trials Let’s connect if you're looking to: Strengthen your API supply chain Launch or expand in regulated markets Partner with a reliable, EU-compliant API manufacturer We’re here to support your success with science, service, and long-term collaboration. Let’s start a conversation. 🤝

1001 to 5000 staff

Acme Generics

Acme is a leading provider of contract manufacturing and development services for oral solid and sterile dosage forms in the pharmaceutical industry. Established in 2005, Acme has evolved into a trusted partner and complete solution provider. Over the years, we have expanded into niche segments such as oral hormones—including both sex hormones and levothyroxine—as well as general injectables, including liquid and lyophilized formulations. Our operations are supported by three state-of-the-art manufacturing facilities. Today, Acme employs over 2,500 highly skilled professionals across its facilities in Northern India. These facilities span approximately sq. ft. and have a robust production capacity of 15 billion tablets, 5 billion capsules, and 42 million ampoules/vials annually. Over the past decade, Acme has been audited and approved by various international regulatory agencies. Our certifications include approvals from USFDA, UK-MHRA, EU-GMP (Hungary), ANVISA (Brazil), PICS (Ukraine), INVIMA (Colombia), WHO-Geneva, and TFDA (Taiwan). We are also recognized by authorities in Nigeria (NAFDAC), Ghana (FDA), Uganda (NDA), Kenya (PPB), Nepal (DDA), Cambodia (DDF), and several other countries, including the Philippines, Vietnam, Niger, Senegal, and Sierra Leone. As we continue our journey, Acme remains dedicated to building a sustainable future. Our commitment to quality, innovation, and regulatory excellence ensures that we deliver high-quality pharmaceutical solutions to global markets.

1001 to 5000 staff

Acme Pharmaceuticals

Founded in 1985, Acme group’s core business lies in providing high quality contract manufacturing services to the patrons of the global health care industry. Backed by our robust team and accredited facilities for more than three decades, we are proud to render an innovative process of bringing high quality oral solid dosage forms, artificial sweeteners and cosmetics in the market. From humble beginnings with a small manufacturing unit outside of Ahmedabad, Acme group is now the trusted partner of 60+ clients, exports to 15+ countries and has a workforce of 400+ people operating across two states. Staying adept with the advancing developments in the pharmaceutical industry, our F&D team actively develops latest formulations and Regulatory team handles accreditation compliance requirements. Connect with our dynamic team to cater your pharmaceutical manufacturing and marketing needs and lay the foundation for mutual growth and success.

201 to 500 staff

Ami Polymer Pvt. Ltd

Ami Polymer Pvt. Ltd.(APPL) is a global manufacturer of silicone elastomeric products and advanced polymeric components, delivering reliable solutions for fluid transfer, sealing, and contamination control since 1998. We serve regulated and performance-driven industries including Biopharma, Pharma, Medical, Laboratory, Food & Beverages, and Engineering worldwide. With ISO Class VII & ISO Class cleanroom facilities and an extensive compliance portfolio-ISO 9001:2015, ISO 14001:2015, ISO 45001:2018, ISO 27001:2013, and ISO 13485:2016-we support customers with quality, traceability, and robust documentation. Our capabilities also include BPOG-standardized extractables, and multiple USFDA DMFs for manufacturing of tubes and hoses. APPL operates with a strong belief in ethical business practices, ensuring quick development, fastest delivery, ultimate quality, and competitive rates. Backed by a 600+ skilled workforce (rubber technologists, biotechnologists, and engineers), we provide end-to-end manufacturing through world-class infrastructure including laser-controlled extrusion, automatic hose production lines, in-house tooling & mould making, advanced R&D and testing, laser cutting, and online marking/printing systems. In April 2024, we expanded our manufacturing strength with a new, world-class facility in Silvassa, India spanning sq. ft, including sq. ft. of cleanroom area, enabling scalable production and faster global fulfillment. Over the years, we’ve successfully developed customized products and serve satisfied customers across the globe through direct supply and distribution networks. Vision: To become a global leader in inflatable seals, pharma tubing, and silicone rubber implants through relentless R&D and empowered teams. Mission: Partnering with the life-sciences community through innovative polymer solutions for affordable healthcare.

501 to 1000 staff

Amoli Organics Limited

Established in 1992,Amoli Organics is a leading manufacturer of APIs with headquarters in Mumbai, India. Amoli has been working collaboratively with some of the leading global healthcare players since 3 decades. Our strength comes from our expertise in process chemistry further bolstered by our EDQM and USFDA approved facilities allowing us to cater to the needs of the pharmaceutical industry globally. We offer APIs from a wide range of therapeutic classes like Antiepileptic, Antidiabetic, Antidepressants,NSAIDS, Hypolipidemics etc. With the support our state-of-the-art R&D centre, we are constantly expanding our product range and foraying into newer therapeutic categories. With a strong team of 1100 employees, Amoli has been able to carve out a place for itself in India's booming pharmaceutical industry. With a stellar regulatory track record, Amoli enjoys the reputation of being a preferred and reliable supplier of several APIs. Our strategy is to keep evolving on all fronts (quality, regulatory and business) in order to remain competitive and relevant in the industry, while ensuring our foundational roots remain intact.

1001 to 5000 staff

Anthem Biosciences Limited

Anthem Biosciences, a Bangalore-India based Contract Research Development Organization (CDMO) Anthem Bio offers a whole gamut of services dedicated to enabling and sustaining global research efforts in the discovery of new compounds by pharmaceutical, biotechnology, specialty chemicals, agriculture chemicals and material science companies. Anthem's core competencies are organic synthesis, process development, analytical chemistry, discovery biology and regulatory compliance. Anthem works extensively with pharma leaders, mid-size to virtual companies across the globe.

1001 to 5000 staff

Arch Pharmalabs, Ltd

Founded in Pharmalabs has gained recognition as a world-class provider of small molecule process chemistry, custom synthesis services and full life-cycle API and drug intermediates manufacture for the global pharmaceutical industry. Generating revenues of USD 200 million, our India-based offering is supported by 2,400 customer-centric Archers, eleven certified facilities (including cGMP-compliant, US FDA- and EDQM-approved sites) and two state-of-the-art Process Technology centres. Arch Pharmalabs works tirelessly to deliver value, innovation and effective supply chain solutions in the spirit of true partnership. Our large family of satisfied customers range from emerging or specialty companies to global majors, many of whom have designated Arch Pharmalabs as a Preferred Supplier or Strategic Partner. Arch Pharmalabs received CNBC TV Emerging India 2006 Award as the No.1 Small or Medium Company in the Pharmaceuticals and Chemicals category.

1001 to 5000 staff

Bec Chemicals Pvt. Ltd

BEC Chemicals Pvt. Ltd specializes in manufacturing of Active pharmaceutical Ingredients (API’s) and Intermediates. The manufacturing unit in Roha (Raigad dist.) has been approved by Indian and European Drug Authority and is EU-GMP, WHO-GMP and State GMP certified. The company is ISO 9001:2008, 14001:2004, OHSAS certified by SGS-UK. The manufacturing unit is a 100% Export Oriented Unit and is recognized as STAR EXPORT house by DGFT (INDIA). Recently we have been approved by USFDA. Products manufactured by BEC Chemicals are: • Ketoprofen • Mesalamine / Mesalazine • Ketoprofen Nitrile • Amino Salicylic Acid (Tech.) BEC Chemicals is an R&D driven company wherein, our Research and Development centre (situated in Mumbai) has been recognized by the Department of Science and Technology as DSIR Approved. The R&D centre's primary focus is to work on Organic Synthesis and developing bio-process technologies for pharmaceutical product lines. We undertake contract research and new process development work for generic APIs under confidentiality agreements. The R&D is well equipped to undertake projects from Lab scale to Kilo scale, with complete technical package as per CTD format. We cater our products to 30 countries across the globe with a firm presence in Europe, South East Asia, Latin America, Middle East and North Africa.

201 to 500 staff

Bhargava Phytolab Pvt. Ltd

With almost a 100 years of experience in providing healthcare and an unbroken commitment to those who rely on our treatments, India based Bhargava Phytolab has today become one of the world's leading homeopathic company. Homeopathy is based on the simple principle of stimulating the body's own healing response. The company uphold the superiority of Homeopathy through expertise supervision of qualified technical professionals following Hahnemanian method. Today, every 3.6 seconds, someone around the world purchases a Bhargava Phytolab product. Making innovation the touchstone of its existence, Bhargava Phytolab has invested in decades of research and development, production as well as marketing of more than products (including generics and branded formulations). The company partners with distributors and retail chains to make homeopathic medicines available to a wide variety of consumers and physician and has thus fulfilled its mission of providing quality medicines at affordable prices to all. Vision : Leveraging nature's finest resources to spread good health across the world. Mission : To develop premier homeopathic medicines which cover a broad spectrum of illnesses and conditions. We want to ensure that customers world over can benefit from easily available, reasonably-priced, safe treatments devoid of side-effects. We also aim to create an international network of partnerships with those who share our values in order to spread health as far and wide as possible. Global Presence : Bhargava Phytolab has its footprints all over the world. We have a strong presence in Asian and European countries. Head quartered in India, Bhargava Phytolab caters to key markets for product supplies and we also keep a close eye on global technology advancements. We plan to expand our operations to even more countries in the coming few years.

501 to 1000 staff

Bioclinica

ERT, the global clinical endpoint technology leader, and Bioclinica, a technological and scientific leader in medical imaging, is now the combined company of Clario. Clario is a technology company that generates the richest clinical evidence by fusing scientific expertise and global scale into the broadest endpoint technology platform. In doing so, Clario empowers its partners to transform lives. Clario is committed to innovating the future of clinical trials through technology and having a positive impact on global healthcare.

1001 to 5000 staff

Biological E. Limited

Biological E. Limited (BE), the first private sector biological products company in India and the first pharmaceuticals company in South India was established in 1953. Originally incorporated as Biological Products Private Limited, and launched by Dr. Vijay Kumar Datla, today, BE is a globally recognised vaccine manufacturer and has supplied over 2 Billion Doses of Vaccines till date all over the world. BE supplies several essential and lifesaving Vaccines and Pharmaceuticals to UN Agencies viz. UNICEF, PAHO, many global markets, and in India to the National Immunization Program, various State Governments, PSUs, Indian Armed Forces and the domestic retail market. With a mission to improve health and survival of people and contribute to the societies BE serves by providing equitable access to quality vaccines and therapeutics. BE has a long and richly textured history of supporting public health programs in India for over five decades. Our portfolio of WHO pre-qualified vaccines include the 5-in-1 Pentavalent and a Japanese Encephalitis vaccine and our future offerings promise to be even more exciting.

1001 to 5000 staff

Bliss Gvs Pharma Ltd

Bliss GVS is a fast-growing Pharmaceutical Company with a proven track record of developing, manufacturing and marketing high quality pharmaceutical formulations at affordable prices for the global market. Today Bliss GVS is among the world leaders in Suppositories and Pessaries dosage forms with one of the largest product portfolio in this segment. The company’s thirty years of experience in suppository manufacturing has resulted in developing an extensive product offering in suppositories and pessaries across various therapeutic categories. Bliss GVS manufacturing plants are certified to be cGMP compliant by local and international standards: EU GMP, WHO GMP, OHSAS-18001 : 2007 and ISO-14001 : 2004. This company is the only EU-GMP certified suppositories manufacturer in India. It is constantly looking to raise the bar in terms of developing innovative products and quality standards which keeps it ahead of competition in this dosage form. This organisation is proud of its segment leadership in Anti-malarial products across most African markets. Its brands cover an extensive range of Artemisinin-based combination formulations across various dosage forms – Tablets, Suspensions, Sachets, Suppositories and Injections. Over the last decade, Bliss GVS has acquired definitive know-how in other dosage forms & therapeutic segments, which is exemplified by its ever-expanding product offering across more than sixty countries. With significant expansion in R&D, Manufacturing & Marketing capabilities. The company is poised for an accelerated rate of growth which makes for very exciting times at Bliss GVS.

501 to 1000 staff